fda warning letters glp-1 september 2025 news Issues to 30 Telehealth Companies Over Misleading Compounded RA Marketing fda glp-1 warning letters september

Timing Baseline Marker Fasting glucose Why it matters Gives a current glucose snapshot, especially when appetite and diabetes medication needs change

The first study to demonstrate the effect of GLP-1RAs in reducing cardiovascular events was LEADER, in which 9340 patients with type 2 diabetes at high cardiovascular risk were randomized to liraglutide 1.8 mg per day or placebo [16]

It is considered a controlled substance that can be addictive and carries the risk of withdrawal symptoms and potential side effects such as a racing or irregular heartbeat

Goldman Sachs analysts also pared back expectations

While not strictly necessary, it can improve and promote the best possible results